No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
B.Riley Financial Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Raises Target Price to $20
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $30
B. Riley Raises Price Target on ClearPoint Neuro to $20 From $15, Keeps Buy Rating
ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0
Top SA Quant-rated Medical Devices Stocks as Technicals Look Strong
ClearPoint Neuro (CLPT) Surges 22.5%: Is This an Indication of Further Gains?